{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:38:57Z","timestamp":1792409937511,"version":"4.4.0"},"reference-count":105,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Cardiovascular disease (CVD) is the leading cause of death in Type 1 Diabetes (T1D). The molecular basis for atherosclerosis in T1D is heavily influenced by hyperglycaemia and its atherogenic effects on LDL. Ongoing research into the distinct pathophysiology of atherosclerosis in T1D offers exciting opportunities for novel approaches to calculate CVD risk in patients with T1D and to manage this risk appropriately. Currently, despite the increased risk of CVD in the T1D population, there are few tools available for estimating the risk of CVD in younger patients. This poses significant challenges for clinicians in selecting which patients might benefit from lipid-lowering therapies over the long term. The current best practice guidance for the management of dyslipidaemia in T1D is generally based on evidence from patients with T2D and the opinion of experts in the field. In this review article, we explore the unique pathophysiology of atherosclerosis in T1D, with a specific focus on hyperglycaemia-induced damage and atherogenic LDL modifications. We also discuss the current clinical situation of managing these patients across paediatric and adult populations, focusing on the difficulties posed by a lack of strong evidence and various barriers to treatment.<\/jats:p>","DOI":"10.3390\/biomedicines9070826","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T10:52:58Z","timestamp":1626432778000},"page":"826","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities"],"prefix":"10.3390","volume":"9","author":[{"given":"Stephen T.","family":"O\u2019Brien","sequence":"first","affiliation":[{"name":"Department of Paediatrics, University Hospital Limerick, V94 F858 Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-0944","authenticated-orcid":false,"given":"Orla M.","family":"Neylon","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Hospital Limerick, V94 F858 Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-5481","authenticated-orcid":false,"given":"Timothy","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, National University of Ireland, H91 TK33 Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: A nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1161\/CIRCULATIONAHA.118.037454","article-title":"Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus","volume":"139","author":"Rawshani","year":"2019","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2337\/diacare.29.02.06.dc05-0724","article-title":"Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: Cross-sectional data from the German diabetes documentation and quality management system (DPV)","volume":"29","author":"Schwab","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2337\/dc06-0310","article-title":"Prevalence of cardiovascular disease risk factors in US children and adolescents with diabetes: The SEARCH for diabetes in youth study","volume":"29","author":"Rodriguez","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00125-007-0921-8","article-title":"High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: A population-based study","volume":"51","author":"Margeirsdottir","year":"2008","journal-title":"Diabetologia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.2337\/db10-0862","article-title":"Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes","volume":"59","author":"Secrest","year":"2010","journal-title":"Diabetes"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","article-title":"High risk of cardiovascular disease in patients with type 1 diabetes in the UK: A cohort study using the general practice research database","volume":"29","author":"Fuller","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.2014.16107","article-title":"Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality","volume":"313","author":"Orchard","year":"2015","journal-title":"JAMA"},{"key":"ref_11","first-page":"j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study","volume":"357","author":"Coupland","year":"2017","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Epidemiology of type 1 diabetes","volume":"39","author":"Maahs","year":"2010","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0002-9149(92)90726-F","article-title":"Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study)","volume":"70","author":"Berenson","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.102.18.2180","article-title":"Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus","volume":"102","author":"Moreno","year":"2000","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"ref_16","first-page":"3527","article-title":"Endothelial cells in physiology and in the pathophysiology of vascular disorders","volume":"91","author":"Cines","year":"1998","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1161\/01.CIR.88.6.2510","article-title":"Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus","volume":"88","author":"Johnstone","year":"1993","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2337\/diab.42.1.80","article-title":"Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells","volume":"42","author":"Kaiser","year":"1993","journal-title":"Diabetes"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(08)60767-9","article-title":"Type 1 diabetes, hyperglycaemia, and the heart","volume":"371","author":"Retnakaran","year":"2008","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1006\/bbrc.1999.1422","article-title":"Oxidation of tetrahydrobiopterin by peroxynitrite: Implications for vascular endothelial function","volume":"263","author":"Milstien","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/diabetes.49.9.1561","article-title":"Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells","volume":"49","author":"Quehenberger","year":"2000","journal-title":"Diabetes"},{"key":"ref_25","first-page":"153","article-title":"Oxidized low density lipoprotein acts on endothelial cells in culture to enhance endothelin secretion and monocyte migration","volume":"19","author":"Achmad","year":"1997","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s001250051308","article-title":"Endothelin: Emerging role in diabetic vascular complications","volume":"42","author":"Hopfner","year":"1999","journal-title":"Diabetologia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/dmrr.196","article-title":"The role of oxidative stress in the onset and progression of diabetes and its complications: Asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes Society","volume":"17","author":"Nawroth","year":"2001","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","article-title":"Current concepts of the pathogenesis of the acute coronary syndromes","volume":"104","author":"Libby","year":"2001","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5551\/jat1994.5.29","article-title":"Immunohistochemical and morphometric evaluations of coronary atherosclerotic plaques associated with myocardial infarction and diabetes mellitus","volume":"5","author":"Fukumoto","year":"1998","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5551\/jat1994.7.132","article-title":"A comparative study of cultured smooth muscle cell proliferation and injury, utilizing glycated low density lipoproteins with slight oxidation, auto-oxidation, or extensive oxidation","volume":"7","author":"Taguchi","year":"2000","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","article-title":"Platelet dysfunction in type 2 diabetes","volume":"24","author":"Vinik","year":"2001","journal-title":"Diabetes Care"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Summerhill, V.I., Grechko, A.V., Yet, S.-F., Sobenin, I.A., and Orekhov, A.N. (2019). The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143561"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","article-title":"Pathophysiology of Diabetic Dyslipidemia","volume":"25","author":"Hirano","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Poznyak, A., Grechko, A.V., Poggio, P., Myasoedova, V.A., Alfieri, V., and Orekhov, A.N. (2020). The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051835"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","article-title":"Metabolic origins and clinical significance of LDLC heterogeneity","volume":"43","author":"Berneis","year":"2002","journal-title":"J. Lipid Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-1-1","article-title":"How hyperglycemia promotes atherosclerosis: Molecular mechanisms","volume":"1","author":"Aronson","year":"2002","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biocel.2005.09.015","article-title":"Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes","volume":"38","author":"Wadwa","year":"2006","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1007\/s00125-006-0281-9","article-title":"Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients","volume":"49","author":"Katakami","year":"2006","journal-title":"Diabetologia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5551\/jat.RV17014","article-title":"Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus","volume":"25","author":"Katakami","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.febslet.2013.05.053","article-title":"High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation","volume":"587","author":"Joshi","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jacc.2018.03.002","article-title":"Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes","volume":"71","author":"Everett","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.5551\/jat.19281","article-title":"Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis","volume":"20","author":"Virella","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.ATV.16.2.222","article-title":"Isolation and characterization of human antioxidized LDL autoantibodies","volume":"16","author":"Mironova","year":"1996","journal-title":"Arter. Thromb Vasc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1464-5491.2006.01905.x","article-title":"Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT\/EDIC cohort: Associations with carotid intima-media thickness","volume":"23","author":"Lyons","year":"2006","journal-title":"Diabet Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/clim.1998.4631","article-title":"Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus","volume":"90","author":"Virella","year":"1999","journal-title":"Clin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIR.0000000000000034","article-title":"Type 1 diabetes mellitus and cardiovascular disease: A scientific statement from the American Heart Association and American Diabetes Association","volume":"130","author":"Fonseca","year":"2014","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.2337\/dc13-2873","article-title":"Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: The FinnDiane study","volume":"37","author":"Tolonen","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/dc08-1775","article-title":"Lipid and lipoprotein profiles in youth with and without type 1 diabetes: The SEARCH for Diabetes in Youth case-control study","volume":"32","author":"Guy","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2337\/diab.41.2.S12","article-title":"Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus","volume":"41","author":"Taskinen","year":"1992","journal-title":"Diabetes"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2337\/dc08-1641","article-title":"Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes","volume":"32","author":"Marcovecchio","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Llaurad\u00f3, G., Amig\u00f3, N., Cano, A., Ballesta, S., Albert, L., Mazarico, I., Fern\u00e1ndez-Veledo, S., Pedro-Botet, J., Vendrell, J., and Gonz\u00e1lez-Clemente, J.-M. (2019). Specific nuclear magnetic resonance lipoprotein subclass profiles and central arterial stiffness in type 1 diabetes mellitus: A case control study. J. Clin. Med., 8.","DOI":"10.3390\/jcm8111875"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2015.10.106","article-title":"Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes","volume":"244","author":"Basu","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12933-018-0802-0","article-title":"Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: A case control study","volume":"17","author":"Gourgari","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2337\/diabetes.51.6.1949","article-title":"Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes","volume":"51","author":"Colhoun","year":"2002","journal-title":"Diabetes"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2213-8587(14)70248-7","article-title":"Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: A systematic review and meta-analysis","volume":"3","author":"Huxley","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1194\/jlr.P060657","article-title":"Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes","volume":"57","author":"Zhang","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1210\/jc.2007-2176","article-title":"Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes","volume":"93","author":"Albers","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-020-01099-0","article-title":"Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: A focus on LDL particles","volume":"19","author":"Amor","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2013.08.014","article-title":"Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk","volume":"230","author":"Damasceno","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00394-018-1777-z","article-title":"Improved adherence to Mediterranean Diet in adults with type 1 diabetes mellitus","volume":"58","author":"Alcubierre","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2016.02.014","article-title":"Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis","volume":"247","author":"Amor","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2018.03.128","article-title":"LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study","volume":"264","author":"Pichler","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/pedi.12742","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents","volume":"19","author":"Donaghue","year":"2018","journal-title":"Pediatric Diabetes"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.2337\/dc21-S013","article-title":"13. Children and Adolescents: Standards of Medical Care in Diabetes\u20142021","volume":"44","author":"Association","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.2337\/dc21-S010","article-title":"10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes\u20142021","volume":"44","author":"Association","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"g4356","DOI":"10.1136\/bmj.g4356","article-title":"Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: Summary of updated NICE guidance","volume":"349","author":"Rabar","year":"2014","journal-title":"BMJ"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCULATIONAHA.115.018844","article-title":"Prediction of first cardiovascular disease event in type 1 diabetes mellitus: The steno type 1 risk engine","volume":"133","author":"Vistisen","year":"2016","journal-title":"Circulation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.numecd.2020.07.006","article-title":"Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes","volume":"30","author":"Boscari","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Llaurad\u00f3, G., Cano, A., Albert, L., Ballesta, S., Mazarico, I., Luchtenberg, M.F., Gonz\u00e1lez-Sastre, M., Meg\u00eda, A., Sim\u00f3, R., and Vendrell, J. (2019). Arterial stiffness is highly correlated with the scores obtained from the Steno Type 1 Risk Engine in subjects with T1DM. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220206"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","article-title":"Cardiovascular risk in type 1 diabetes mellitus","volume":"10","author":"Schofield","year":"2019","journal-title":"Diabetes Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e002882","DOI":"10.1161\/JAHA.115.002882","article-title":"Progression of Electrocardiographic Abnormalities in Type 1 Diabetes During 16 Years of Follow-up: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study","volume":"5","author":"Soliman","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1007\/s00125-019-05009-2","article-title":"Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: The Thousand & 1 Study","volume":"62","author":"Jensen","year":"2019","journal-title":"Diabetologia"},{"key":"ref_76","first-page":"160","article-title":"Lipid profile and nutritional intake in children and adolescents with type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet","volume":"35","author":"Cadario","year":"2012","journal-title":"J. Endocrinol. Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1758-5996-2-47","article-title":"Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial","volume":"2","author":"Salem","year":"2010","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jdiacomp.2012.05.011","article-title":"Correlation of cardiorespiratory fitness with risk factors for cardiovascular disease in children with type 1 diabetes mellitus","volume":"26","author":"Miculis","year":"2012","journal-title":"J. Diabetes Complicat."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpeds.2012.06.006","article-title":"Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes","volume":"162","author":"Maahs","year":"2013","journal-title":"J. Pediatr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00125-007-0870-2","article-title":"Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type 1 diabetes","volume":"51","author":"Franklin","year":"2008","journal-title":"Diabetologia"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/jama.2017.1628","article-title":"The DASH diet, 20 years later","volume":"317","author":"Steinberg","year":"2017","journal-title":"JAMA"},{"key":"ref_83","first-page":"e603","article-title":"Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association","volume":"139","author":"Steinberger","year":"2019","journal-title":"Circulation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-015-0692-4","article-title":"Challenges and opportunities in the management of cardiovascular risk factors in youth with type 1 diabetes: Lifestyle and Beyond","volume":"15","author":"Katz","year":"2015","journal-title":"Curr. Diabetes Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/bcp.13482","article-title":"Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: Long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use","volume":"84","author":"Ahmadizar","year":"2018","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/jpem-2018-0383","article-title":"Prevalence of dyslipidemia and factors affecting dyslipidemia in young adults with type 1 diabetes: Evaluation of statin prescribing","volume":"32","author":"Abed","year":"2019","journal-title":"J. Pediatric Endocrinol. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/ATVBAHA.107.145151","article-title":"A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia","volume":"27","author":"Avis","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3476(03)00186-0","article-title":"Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: A multicenter, randomized, placebo-controlled trial","volume":"143","author":"McCrindle","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and Safety of Statin Therapy in Children With Familial HypercholesterolemiaA Randomized Controlled Trial","volume":"292","author":"Wiegman","year":"2004","journal-title":"JAMA"},{"key":"ref_90","first-page":"65","article-title":"Pediatric Atorvastatin in Diabetes Trial (PADIT): A pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus","volume":"22","author":"Haller","year":"2009","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Dalton, R., Marshall, S., Neil, H., Bond, S., Daneman, D., Dawson, S., Jones, T., Chiesa, S., Marcovecchio, M., and Donaghue, K. (2017). ACE inhibitors and statins in adolescents with type 1 diabetes. N. Eng. J. Med., 377.","DOI":"10.1056\/NEJMoa1703518"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1701-2163(16)32656-1","article-title":"Motherisk Rounds: Risks of Statin Use During Pregnancy: A Systematic Review","volume":"29","author":"Kazmin","year":"2007","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: A systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2337\/diacare.28.5.1151","article-title":"Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial\u2013lipid-lowering arm (ASCOT-LLA)","volume":"28","author":"Sever","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"E2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: A meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2337\/db05-1423","article-title":"The 30-year natural history of type 1 diabetes complications: The Pittsburgh Epidemiology of Diabetes Complications Study experience","volume":"55","author":"Pambianco","year":"2006","journal-title":"Diabetes"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs. type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.009","article-title":"Prospective association between diabetic retinopathy and cardiovascular disease\u2014a systematic review and meta-analysis of cohort studies","volume":"25","author":"Guo","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/heartjnl-2014-305657","article-title":"Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus","volume":"100","author":"Brownrigg","year":"2014","journal-title":"Heart"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"12807","DOI":"10.3390\/ijms150712807","article-title":"Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease","volume":"15","author":"Orekhov","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2337\/db19-0358","article-title":"Immune complexes and the risk of CVD in type 1 diabetes","volume":"68","author":"Bebu","year":"2019","journal-title":"Diabetes"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/7\/826\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:31:28Z","timestamp":1760164288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/7\/826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":105,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["biomedicines9070826"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9070826","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]}}}